Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New nerve block may ease pain after gallbladder removal

NCT ID NCT06712498

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a specific nerve block, called the external oblique intercostal plane block, can reduce pain and improve satisfaction in patients undergoing laparoscopic gallbladder removal. Sixty-four adults aged 18-65 received either the nerve block with bupivacaine or no block. Researchers measured pain scores and how much pain medication patients needed after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bupivacaine
What this could lead to
If successful, this nerve block could become a standard way to manage pain after gallbladder surgery, reducing the need for strong painkillers.
What could go wrong
This is a small, completed study with only 64 participants. The results may not apply to all patients, and nerve blocks carry rare risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

64 people

The number who actually took part.

Started

Nov 2024

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

operating

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 18-65 * and with ASA1-2 were included. Exclusion Criteria:• Patients younger than 18 years of age and older than 65 years of age * Patients allergic to local anesthetics * Patients with opioid and alcohol addiction * Patients with perioperative signs of acute cholecystitis * Patients with contraindications for laparoscopic surgery * Cases with ASA III-IV were not included in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laparoscopic cholecystectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Health Sciences University Gazi Yaşargil Training and Research Hospital

    Diyarbakır, Kayapınar, 21070, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.